Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 268
Selected: 0
NCT IDTitle
NCT03320161A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT00227669Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
NCT01717924Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma
NCT02773004Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer
NCT00003652Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
NCT04450836Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
NCT02843386Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
NCT03080428Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer
NCT03943667Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma
NCT00006111Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
NCT00053911Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
NCT03726775Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN
NCT01564056Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
NCT01994239Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy
NCT02363751Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)
NCT02539537A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
NCT01247233Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer
NCT07262489Neo-adjuvant Immunotherapy Master Trial for Localized Cancers
NCT06450314Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.
NCT00056095Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
NCT05973864Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
NCT06756802Reproductive Health in Breast Cancer Survivor
NCT07340619Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
NCT00006119Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma
NCT00104741Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
NCT03777813Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer
NCT06446882Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT00002870High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
NCT05440396Identifying Local Signs at the Catheter Insertion Site With Artificial Intelligence
NCT05639413A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NCT00104624Docetaxel in Treating Older Women With Metastatic Breast Cancer
NCT02215265Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
NCT01363466Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer
NCT07151586Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer
NCT02701907EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies
NCT00112658Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
NCT00411138Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
NCT00003607Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00054587Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
NCT04790253PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT01022918Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma
NCT06529718Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
NCT04181203Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
NCT02967289IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting
NCT07193394Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
NCT00066274Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
NCT00287846Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
NCT05078047Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT00104689Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer